Kinnevik AB (publ) 13FHR Quarterly holdings report by institutional manager | SEC 25 Jul 23

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
Recursion Pharmaceuticals, Inc.	CL A SHS	75629V104	77,730,340	10,405,668	SH		DFND	1	10,405,668	0	0

Kinnevik AB (publ) 13F-HRQuarterly holdings report by institutional manager